Free Stock & ETF Comparisons
1622+ side-by-side comparisons with AI scores, valuation metrics, performance charts, analyst targets, and investor takeaways. No sign-in required.
- AI investment scores (0–100) for each stock
- Valuation metrics: P/E, forward P/E, PEG, EV/EBITDA
- Performance charts across 1M to 10Y timeframes
- Analyst price targets and upside estimates
- AI-written investor thesis and side-by-side takeaways
Browse Comparisons
Compare Amarin and Docgo by Vascepa cardiovascular drug revenue sustainability post-generic entry, mobile health clinic government contract revenue, and which healthcare micro-cap is the better risk/reward proposition.
Compare Progyny and ACM Research by employer fertility benefits ARR, semiconductor wafer cleaning equipment revenue in China, TAM expansion, and which small/mid-cap growth company has more predictable near-term revenue.
Compare STAAR Surgical and Beam Therapeutics by EVO implantable collamer lens revenue growth vs base editing gene therapy clinical data, profitability timeline, and which medical innovation company is more suitable for growth-at-a-reasonable-price investors.
Compare Cross Country Healthcare and AMN Healthcare by travel nurse placement revenue normalisation, workforce solutions technology ARR, and which healthcare staffing company is better positioned as hospital labor markets normalise post-pandemic.
Compare Hut 8 and Marathon Digital Holdings by Bitcoin mining hashrate, cost per BTC mined, energy mix and power purchase agreements, BTC on balance sheet, and which publicly traded Bitcoin miner has the more efficient and lower-risk operation.
Compare TPI Composites and Viasat by wind turbine blade outsourced manufacturing revenue, ViaSat-3 satellite broadband ARPU, government defense communication contracts, and which capital-intensive growth company is the better turnaround bet.
Compare Phathom Pharmaceuticals and Arrowhead Pharmaceuticals by vonoprazan acid-related disease launch, RNAi liver-targeted therapy pipeline breadth, partnership revenue, and which specialty biotech is closer to self-sustaining cash flow.
Compare RxSight and Amphora by light adjustable intraocular lens post-cataract revenue ramp, specialty drug delivery device market, and which niche medical device company is capturing a new surgical standard of care.
Compare Glaukos and Amedisys by iDose sustained-release glaucoma drug delivery ARR, home health visit reimbursement, hospice admission growth, and which specialty healthcare company has more durable recurring revenue.
Compare Procept BioRobotics and Silk Road Medical by AquaBeam BPH robotic surgery adoption, TCAR carotid stenting device procedure growth, and which small-cap medical device company builds the more defensible clinical procedure moat.
Compare TransMedics and Butterfly Network by Organ Care System transport device revenue, handheld ultrasound probe subscription model, and which breakthrough medical device platform is on a faster path to hospital standard of care.
Compare RLI Corp and Kinsale Capital by excess and surplus lines specialty niche underwriting, combined ratio discipline, technology-driven pricing sophistication, and which specialty E&S insurer is the better long-term compounder.
Compare IonQ and Rigetti Computing by quantum volume benchmarks, government contract revenue, cloud access pricing, and which quantum computing company is closer to demonstrating practical quantum advantage for enterprise applications.
Compare D-Wave Quantum and IonQ by quantum annealing real-world optimization use cases, trapped-ion gate fidelity, commercial cloud revenue, and which quantum computing approach reaches enterprise ROI-positive applications first.
Compare Portillo's and Darden Restaurants by unit economics, same-restaurant sales growth, Portillo's limited market expansion opportunity vs Darden's Olive Garden/LongHorn moat, and which restaurant operator is the better compounding investment.
Compare BJ's Restaurants and Texas Roadhouse by beer/restaurant combo traffic driver, menu price elasticity, labor cost as % of revenue, and which casual dining chain delivers more consistent comparable restaurant sales growth.
Compare PTC Therapeutics and TriplePoint Venture Growth by rare disease drug (Translarna/Upstaza) launch trajectory, venture lending BDC net investment income, and which smaller income/growth security is more suitable for an income-growth barbell portfolio.
Compare Olaplex's professional bond-building hair care brand recovery, professional channel vs retail pricing dynamics, and Terra Property's commercial real estate loan portfolio health, as two very different small-cap equity stories.
Compare Medallion Financial and CSW Industrials by taxi medallion loan portfolio evolution, HVAC/plumbing specialty product revenue, and which small-cap specialty company compounds more predictably through economic cycles.
Compare Civitas Resources and Permian Resources by DJ Basin vs Delaware Basin oil production growth, free cash flow yield, variable dividend sustainability, and which mid-size E&P operator has more consistent capital return to shareholders.
Compare Vaalco Energy and Green Plains by West Africa offshore oil production, sustainable aviation fuel (SAF) ethanol conversion opportunity, and which small-cap energy company has a more compelling transition story.
Compare BRT Realty Trust and LXP Industrial Trust by multi-tenant commercial property vs net lease industrial property cap rates, rent roll-up potential, and which diversified REIT provides better inflation protection through industrial real estate.
Compare Alexander & Baldwin and CARBO Ceramics by Hawaii commercial real estate and agriculture land monetization strategy, hydraulic fracturing proppant demand, and which niche asset-heavy company creates more value through its unique land or material position.
Compare Revolution Medicines and Kymera Therapeutics by KRAS G12C inhibitor revenue, RAS(ON) multi-selective program, targeted protein degradation IRAK4/STAT6 pipeline, and which oncology-focused biotech has higher near-term catalyst probability.
Compare Arcutis Biotherapeutics and Coherus BioSciences by Zoryve cream/foam dermatology launch trajectory, Humira/Eylea biosimilar revenue ramp, and which specialty biopharma navigates its niche commercial launch more efficiently.
Compare Avadel Pharmaceuticals and Innoviva by LUMRYZ narcolepsy once-nightly oxybate launch, Innoviva FTSE/Relvar royalty income, and which specialty pharmaceutical model — commercial launch vs royalty stream — is the better risk-adjusted investment.
Compare Simmons First National and OFG Bancorp by Mid-South commercial lending NIM, Puerto Rico/Virgin Islands consumer banking growth, credit quality, and which community/regional bank offers a better risk-adjusted dividend income.
Compare Plumas Bank and First Citizens BancShares by agricultural lending niche vs SVB/CIT acquisition integration, community banking NIM, and which bank is better managed given their different scale and specialty lending focus.
Compare Stellar Bancgroup and Northwest Bancshares by community commercial and consumer banking NIM, construction loan quality, deposit beta in a rate cycle, and which mid-size community bank is better positioned for a soft-landing credit environment.
Compare Knowles Corporation and Mesa Labs by MEMS microphone content per flagship smartphone, specialty calibration instruments recurring calibration service revenue, and which precision component or instrument company delivers more consistent through-cycle earnings.
Compare Circle Internet Group and Coinbase by stablecoin economics, USDC exposure, crypto trading revenue, regulatory tailwinds, profitability, and which digital asset platform has better long-term upside.
Compare SpaceX and AST SpaceMobile by satellite constellation strategy, Starlink vs BlueBird broadband, and space connectivity investing.
Compare SpaceX and Amazon by satellite broadband strategy, Starlink vs Kuiper, launch market dominance, and space connectivity investment.
Compare Circle Internet Group and PayPal by stablecoin USDC economics, payments infrastructure, crypto integration, and digital finance investing.
Compare Circle and Block by stablecoin revenue, Bitcoin treasury strategy, merchant payments, and which digital finance company is better positioned.
Compare Circle and Robinhood by crypto finance positioning, USDC vs retail crypto trading, and digital asset infrastructure investing.
Compare Circle Internet Group and MicroStrategy by stablecoin vs Bitcoin exposure, revenue models, and crypto investment thesis.
Compare Coinbase and ProShares Bitcoin ETF by crypto market exposure mechanism, operating leverage vs passive tracking, futures roll cost, regulatory risk, and which vehicle is better for investors wanting crypto-adjacent returns.
Compare GBTC and MicroStrategy by Bitcoin holdings per share, premium/discount to NAV, operating business vs pure-play treasury overlay, liquidity, and which Bitcoin holding vehicle is better for investors seeking BTC exposure.
Compare Intuitive Machines and AST SpaceMobile by lunar delivery and infrastructure contracts vs direct-to-device broadband constellation deployment, revenue ramp timeline, burn rate, and which space economy company offers better risk-reward.
Compare Arqit Quantum and IonQ by quantum key distribution vs universal quantum computing approach, government contract traction, revenue visibility, cash runway, and which quantum technology company offers better near-term commercial viability.
Compare Rigetti Computing and IBM by superconducting qubit architecture, quantum volume milestones, cloud quantum access revenue, enterprise partnership depth, and which quantum computing exposure offers better risk-adjusted access to the quantum era.
Compare Archer Aviation and Eve Holding by FAA certification progress, aircraft design approach, strategic partnership quality (United Airlines vs EmbraerX), capital efficiency, and which electric air taxi company is closer to commercial operations.
Compare SoundHound AI and BigBear.ai by conversational AI vs national security intelligence analytics, revenue growth quality, customer concentration, AI model differentiation, and which small-cap AI company offers better defensible revenue growth.
Compare AVUV and IJS by factor-tilted vs market-cap-weighted small-cap value approach, profitability screen inclusion, expense ratio, historical factor premium capture, and which small-cap value ETF is better for long-term factor investors.
Compare Robinhood and Strategy (formerly MicroStrategy) by business model, crypto exposure, revenue diversification, and speculative stock investment risk.
Compare Archer Aviation and Vertical Aerospace by certification progress, manufacturing partnerships, cash runway, and speculative eVTOL stock investment risk.
Compare SpaceX and AST SpaceMobile by business model scale, satellite constellation strategy, revenue diversification, and space stock investment risk.
Sign in to access the full platform — compare any stocks, build watchlists, and get AI-powered portfolio insights.
Start Free Trial